| pubmed-article:15962453 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15962453 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15962453 | lifeskim:mentions | umls-concept:C0235394 | lld:lifeskim |
| pubmed-article:15962453 | lifeskim:mentions | umls-concept:C0015259 | lld:lifeskim |
| pubmed-article:15962453 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15962453 | lifeskim:mentions | umls-concept:C0887947 | lld:lifeskim |
| pubmed-article:15962453 | lifeskim:mentions | umls-concept:C1516240 | lld:lifeskim |
| pubmed-article:15962453 | lifeskim:mentions | umls-concept:C0384570 | lld:lifeskim |
| pubmed-article:15962453 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:15962453 | pubmed:dateCreated | 2005-6-8 | lld:pubmed |
| pubmed-article:15962453 | pubmed:abstractText | Over 700 patients with HIV-associated wasting while receiving HAART were randomly assigned to double-blind treatment for 12 weeks with recombinant human growth hormone (rhGH) daily or on alternate days, or to placebo. Maximum exercise intensity increased by a median of 2.35kJ in the alternate-days group and 2.60 kJ in the daily group but decreased by 0.25kJ in the placebo group. The median difference between the daily and placebo groups was 2.85 kJ (P < .0001). These improvements suggest that rhGH treatment may enable patients with wasting to perform activities of daily living that would be exhausting without rhGH treatment. | lld:pubmed |
| pubmed-article:15962453 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15962453 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15962453 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15962453 | pubmed:citationSubset | X | lld:pubmed |
| pubmed-article:15962453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15962453 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15962453 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15962453 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15962453 | pubmed:issn | 1053-0894 | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:KotlerDonald... | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:StaszewskiSch... | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:EvansWilliam... | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:GriffinGeorge... | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:IsgaardJorgen... | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:SvanbergElisa... | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:GertnerJoseph... | lld:pubmed |
| pubmed-article:15962453 | pubmed:author | pubmed-author:O'BrienFannyF | lld:pubmed |
| pubmed-article:15962453 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15962453 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:15962453 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15962453 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15962453 | pubmed:pagination | 301-3, 306-8, 310, 314 | lld:pubmed |
| pubmed-article:15962453 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:meshHeading | pubmed-meshheading:15962453... | lld:pubmed |
| pubmed-article:15962453 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15962453 | pubmed:articleTitle | Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART. | lld:pubmed |
| pubmed-article:15962453 | pubmed:affiliation | Donald W. Reynolds Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. | lld:pubmed |
| pubmed-article:15962453 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15962453 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15962453 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15962453 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15962453 | lld:pubmed |
